Geographic Atrophy Market

Jul 01, 2020

10 likes | 15 Vues

The total diagnosed cases of Geographic Atrophy in the 7MM were found to be 2,516,401 in 2017. The market size of Geographic Atrophy in 7MM was USD 276 Million in 2017, which is expected to grow during the study period, i.e., 2017u20132030. Increasing prevalence rate, emerging novel treatment options, and patient-friendly dosage regimes are some of the key factors expected to drive the Geographic Atrophy Market forward in the coming years. The key players in the Geographic Atrophy Market includes Apellis Pharmaceuticals, IVERIC bio, Alkeus Pharmaceuticals, Hemera Biosciences, Allegro Ophthalmics, Stealth BioTherapeutics, Gyroscope Therapeutics Limited, Regenerative Patch Technologies LLC, Roche, Ionis Pharmaceuticals, Cell Cure Neurosciences, Janssen Pharmaceutica and others. For more detailed information on Geographic Atrophy Market, visit: https://www.delveinsight.com/report-store/geographic-atrophy-ga-market

DelveInsight

Télécharger la présentation

Geographic Atrophy Market

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D